43238 Federal Register / Vol. 82, No. 177 / Thursday, September 14, 2017 / Notices 

ACTION: Notice of meeting. 

SUMMARY: In accordance with section 

10(a)(2) of the Federal Advisory 

Committee Act, the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

Advisory Committee on Immunization 

Practices (ACIP). 

This meeting is open to the public, 

limited only by the space available. 

Time will be available for public 

comment. The public is welcome to 

submit written comments in advance of 

the meeting. Comments should be 

submitted in writing by email to the 

contact person listed below. The 

deadline for receipt is October 11, 2017. 

Written comments must include full 

name, address, organizational 

affiliation, email address of the speaker, 

topic being addressed and specific 

comments. Written comments must not 

exceed one single-spaced typed page 

with 1-inch margins containing all items 

above. Only those written comments 

received 10 business days in advance of 

the meeting will be included in the 

official record of the meeting. Public 

comments made in attendance must be 

no longer than 3 minutes and the person 

giving comments must attend the public 

comment session at the start time listed 

on the agenda. Time for public 

comments may start before the time 

indicated on the agenda. The meeting 

will be webcast live via the World Wide 

Web; for instructions and more 

information on ACIP please visit the 

ACIP Web site: http://www.cdc.gov/ 

vaccines/acip/index.html. 

DATES: The meeting will be held on 

October 25, 2017, 8:00 a.m. to 6:00 p.m., 

EDT, and October 26, 2017 8:00 a.m. to 

3:15 p.m. EDT. 

ADDRESSES: 1600 Clifton Road NE., 

Atlanta, GA 30329, CDC, Tom Harkin 

Global Communications Center, Kent 

‘Oz’ Nelson Auditorium. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, CDC, NCIRD; 

email: ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters to be Considered: The agenda 

will include discussions on adult 

immunization schedule, child/ 

adolescent immunization schedule, 

influenza vaccines, anthrax vaccine, 

Japanese encephalitis vaccines, hepatitis 

vaccines, herpes zoster vaccines, human 

papillomavirus vaccines, mumps 

vaccine, pneumococcal vaccines, 

respiratory syncytial virus vaccine and 

immunization safety update. A 

recommendation vote is scheduled for 

adult immunization schedule, child/ 

adolescent immunization schedule, 

hepatitis vaccines and herpes zoster 

vaccines. A Vaccines for Children vote 

is scheduled for hepatitis vaccines. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–19497 Filed 9–13–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting. 

The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 

5 U.S.C., and the Determination of the 

Director, Management Analysis and 

Services Office, CDC, pursuant to Pub. 

L. 92–463. 

Name of Committee: Safety and 

Occupational Health Study Section (SOHSS), 

National Institute for Occupational Safety 

and Health (NIOSH). 

Date: October 31–November 1, 2017. 

Time: 8:00 a.m.–5:00 p.m., CST. 

Place: The Wit Hotel, 201 North State 

Street, Chicago, Illinois 60601. 

Agenda: The meeting will convene to 

address matters related to the conduct of 

Study Section business and for the study 

section to consider safety and occupational 

health-related grant applications. 

For Further Information Contact: Price 

Connor, Ph.D., NIOSH Health Scientist, CDC 

2400 Executive Parkway, Atlanta, Georgia 

30345, (404) 498–2511, spc3@cdc. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–19500 Filed 9–13–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting. 

The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 

5 U.S.C., and the Determination of the 

Director, Management Analysis and 

Services Office, CDC, pursuant to Public 

Law 92–463. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—PAR 13–129, NIOSH 

Member Conflict Special Emphasis Panel. 

Date: October 25, 2017. 

Time: 1:00 p.m.–5:00 p.m., EDT. 

Place: Teleconference. 

Agenda: The meeting will include the 

initial review, discussion, and evaluation of 

applications received in response to PAR 13– 

129, NIOSH Member Conflict Special 

Emphasis Panel. 

For FuRther Information Contact: Nina 

Turner, Ph.D. Scientific Review Officer, CDC, 

1095 Willowdale Road, Morgantown, West 

Virginia 26506, (304) 285–5976, nxt2@

cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 


asabaliauskas on DSKBBXCHB2PROD with NOTICES